ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in St Louis, MO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Lung Diseases
Rhinitis
Chronic Obstructive Pulmonary Disease
Disease
Dust Mite Allergy

Asthma trials near St Louis, MO, USA:

Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma. (ARRIVAL)

administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma..Study det...

Active, not recruiting
Severe Asthma
Combination Product: Budesonide/formoterol
Combination Product: Mannitol

Phase 3

AstraZeneca
AstraZeneca

St Louis, Missouri, United States and 70 other locations

This is a multi-center, double-blind, placebo-controlled, randomized trial of dupilumab adjunctive therapy for prevention of asthma exacerba....

Active, not recruiting
Asthma
Drug: Placebo
Drug: Dupilumab

Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

St Louis, Missouri, United States and 7 other locations

dose-range finding study in adults with moderate to severe asthma to confirm the dosing regimen of WIN378 that can be tested in future pivot...

Enrolling
Asthma
Drug: Placebo
Drug: WIN378

Phase 2

Windward Bio

St Louis, Missouri, United States and 72 other locations

A Phase 2, open-label, single-arm trial to evaluate IV rademikibart as an add-on treatment for acute exacerbation in participants with asthma...

Enrolling
Asthma Acute
COPD Exacerbation Acute
Drug: Rademikibart

Phase 2

Connect Biopharm LLC

St Louis, Missouri, United States and 2 other locations

Locations recently updated

The objective of this study is to assess the potential for GB-0895 to improve the health of adolescents and adults with severe asthma that i...

Enrolling
Severe Asthma
Drug: GB-0895
Drug: Placebo

Phase 3

Generate Biomedicines

St Louis, Missouri, United States and 156 other locations

and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroi...

Enrolling
Asthma
Drug: ENV-294
Drug: Placebo

Phase 2

Enveda Therapeutics

St Louis, Missouri, United States and 24 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

St Louis, Missouri, United States and 335 other locations

Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and wor...

Enrolling
Asthma
Biological: Depemokimab

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

St Louis, Missouri, United States and 49 other locations

This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...

Active, not recruiting
Asthma
Drug: GSK5784283
Drug: Placebo

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

St Louis, Missouri, United States and 137 other locations

PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, ...

Enrolling
Asthma
Other: Placebo
Drug: PF-07275315

Phase 2

Pfizer
Pfizer

St Louis, Missouri, United States and 136 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems